Oppenheimer analyst Jay Olson downgraded Sage Therapeutics (NASDAQ: SAGE) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Downgrades

Oppenheimer Reiterates Perform Rating on Sage Therapeutics (SAGE)August 7, 2023 4:56 PM SAGE Therapeutics (SAGE) sinks nearly 50% as trading resumes following CRLAugust 7, 2023 7:12 AM